Policy,

to the point.

Health policy is complex.
Your next move doesn't have to be.

Apteka helps pharmaceutical companies and advocacy organizations turn policy noise into clear strategic decisions through policy intelligence, strategic advisory, and policy shaping. We work with you to stop reacting to everything and start getting ahead of what matters.

Trusted by leading pharmaceutical manufacturers, national advocacy organizations, and emerging biotech.

25 years across payer organizations, government, pharmaceutical manufacturers, and consulting.

Who Apteka Works With.

Apteka works with organizations navigating the intersection of pharmaceutical policy and commercial strategy, where decisions directly affect coverage, revenue, and patient access.

Established and emerging pharmaceutical manufacturers

Market Access, Government Affairs, and policy leaders who need to know what matters and what doesn’t. Some are in lean organizations where one person is covering policy, access, and government affairs simultaneously. Others are inside large companies where policy and commercial teams speak different languages. The problem is the same either way: too much noise, not enough bandwidth to sort it.

Advocacy organizations and coalitions

National groups working to influence policy while maintaining credibility. They need external expertise that can develop white papers and issue briefs that shape the conversation, not deliverables that sit in a folder.

"Apteka is part of our team."

— Executive Director, Rare Access Action Project

Complex policy, high stakes, not enough time to see the whole board.

Apteka has worked on the manufacturer side, the payer side, the wholesaler side.

We know what each of them is thinking, which means your strategy doesn’t fall apart because you missed an angle.

Unlike other agencies that just quote publicly available policy reports, Apteka brings an insider’s perspective that greatly enhances the value of the content.

— Senior Director, Market Access, Mid-Sized Pharma

Pharma companies and advocacy organizations, here's where most clients start:

Apteka works with organizations navigating the intersection of pharmaceutical policy and commercial strategy, where decisions directly affect coverage, revenue, and patient access.

You’re drowning in information

A new rule drops and you need to know fast: does this matter, or is it noise? You need a sounding board, not another newsletter to get to at some point. Most people here start with a Policy & Access Clarity Session or Policy Intelligence Briefing.

You need a thought partner

Your internal team is capable. What they need is an outside perspective that understands the policy landscape as well as they understand the business: someone to pressure-test strategy, fill the gaps, and show up ready when it matters.

You need to cut through the noise

Your internal team is capable. What they need is an outside perspective that understands the policy landscape as well as they understand the business: someone to pressure-test strategy, fill the gaps, and show up ready when it matters.

Most clients start with a 30-minute call to figure out exactly what they need.

AMP is WAC.

Policy updates with personality.

AMP is WAC breaks down what’s happening in health policy, what it means, why it matters, and what to do about it. No jargon. No fluff. Just the signal, with the occasional bad pun.

Get weekly policy updates.

No spam. Unsubscribe anytime. We respect your inbox.

"It becomes part of my thinking and influences how I approach my business."

— Senior Director of Product Strategy, PBM

Apteka intentionally works with a limited number of organizations at a time, intentionally.

So you get direct access and high-touch support that actually moves decisions.
Most organizations start with a short conversation to determine whether there’s a fit.